Which anti thyroid drug can be safely used in pregnancy
**Core Concept:**
Anti-thyroid drugs (ATDs) are medications used to treat hyperthyroidism (overactive thyroid) by suppressing thyroid hormone production and/or secretion. They can be categorized based on their mechanism of action, with thionamides being the most common class of ATDs.
**Why the Correct Answer is Right:**
The correct answer, methimazole (Tapazole), is a thionamide anti-thyroid drug that is widely used for the treatment of hyperthyroidism. It works by inhibiting the enzyme DIO1 (Dioxygenase Iodothyronine Type 1) which is involved in the synthesis of thyroid hormones, particularly thyroxine (T4) and triiodothyronine (T3). Methimazole is the preferred choice for pregnancy, as it is less likely to cross the placenta than carbimazole, another thionamide anti-thyroid drug. This reduced placental passage results in a lower risk of fetal toxicity and congenital anomalies compared to carbimazole.
**Why Each Wrong Option is Incorrect:**
A. Carbimazole is another thionamide anti-thyroid drug, but it exhibits higher placental passage and can cause more fetal toxicity and congenital anomalies, making it unsuitable for use during pregnancy.
B. Propylthiouracil is another thionamide anti-thyroid drug but it is not commonly used due to its higher risk of fetal toxicity and congenital anomalies compared to methimazole.
C. Thionamides are the class of anti-thyroid drugs, but the specific drug choices provided are methimazole and carbimazole.
D. Propylthiouracil is used in hyperthyroidism treatment, but it is generally avoided during pregnancy due to its higher risk of fetal toxicity and congenital anomalies compared to methimazole.
**Clinical Pearl:**
The choice of anti-thyroid drug during pregnancy depends on the severity of hyperthyroidism and the patient's individual circumstances. In general, methimazole is preferred due to its lower risk of fetal toxicity and congenital anomalies compared to carbimazole and propylthiouracil. However, the final decision is made after considering the patient's condition and fetal risk factors.